Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Riederer

Showing results (101-110 of 587) with videos related to

Pageof 59
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|August 2, 2001
Neurotransmission in HIV associated dementia: a short reviewE Koutsilieri, V ter Meulen, P Riederer
Clinical Neuropharmacology|January 1, 1982
(-)Deprenyl in the treatment of Parkinson's diseaseW Birkmayer, P Riederer, M B Youdim
Neuroscience and Biobehavioral Reviews|July 1, 1997
Dopamine/glutamate interactions in Parkinson's diseaseK W Lange, J Kornhuber, P Riederer
Brain Research|June 12, 1989
Regional distribution of [3H]MK-801 binding sites in the human brainJ Kornhuber, F Mack-Burkhardt, P Riederer
Journal of Molecular Medicine (Berlin, Germany)|July 1, 1996
The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processesK P Lesch, A Heils, P Riederer
Biochemical Pharmacology|June 29, 1995
Neuroprotective therapeutic strategies. Comparison of experimental and clinical resultsM Gerlach, P Riederer, M B Youdim
Journal of the Royal Society of Medicine|September 1, 1981
Tranylcypromine isomers and Parkinson's disease: new aspects of an old drugG P Reynolds, P Riederer, M Sandler
Journal of Neural Transmission. Supplementum|January 1, 1994
Is selegiline neuroprotective in Parkinson's disease?M Gerlach, M B Youdim, P Riederer
Journal of Neural Transmission. Supplementum|January 1, 1990
Oxidative stress: a role in the pathogenesis of Parkinson's diseaseM E Götz, A Freyberger, P Riederer
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?M B Youdim, D Ben-Shachar, P Riederer
Pageof 59

Showing results (101-110 of 587) with videos related to

Sort By:
Pageof 59
Journal of Neural Transmission (Vienna, Austria : 1996)|August 2, 2001
Neurotransmission in HIV associated dementia: a short reviewE Koutsilieri, V ter Meulen, P Riederer
Clinical Neuropharmacology|January 1, 1982
(-)Deprenyl in the treatment of Parkinson's diseaseW Birkmayer, P Riederer, M B Youdim
Neuroscience and Biobehavioral Reviews|July 1, 1997
Dopamine/glutamate interactions in Parkinson's diseaseK W Lange, J Kornhuber, P Riederer
Brain Research|June 12, 1989
Regional distribution of [3H]MK-801 binding sites in the human brainJ Kornhuber, F Mack-Burkhardt, P Riederer
Journal of Molecular Medicine (Berlin, Germany)|July 1, 1996
The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processesK P Lesch, A Heils, P Riederer
Biochemical Pharmacology|June 29, 1995
Neuroprotective therapeutic strategies. Comparison of experimental and clinical resultsM Gerlach, P Riederer, M B Youdim
Journal of the Royal Society of Medicine|September 1, 1981
Tranylcypromine isomers and Parkinson's disease: new aspects of an old drugG P Reynolds, P Riederer, M Sandler
Journal of Neural Transmission. Supplementum|January 1, 1994
Is selegiline neuroprotective in Parkinson's disease?M Gerlach, M B Youdim, P Riederer
Journal of Neural Transmission. Supplementum|January 1, 1990
Oxidative stress: a role in the pathogenesis of Parkinson's diseaseM E Götz, A Freyberger, P Riederer
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?M B Youdim, D Ben-Shachar, P Riederer
Pageof 59